Bahl & Gaynor Inc Medpace Holdings, Inc. Transaction History

Bahl & Gaynor Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 11, 2018	SELL	$32.03 - $39.05 $846,713 - $1.03 Million	-26,435 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$32.46 - $38.31 $14,120 - $16,664	435 Added 1.67%	26,435 $959,000
Q3 2017 Nov 13, 2017	BUY	$27.43 - $33.11 $112,051 - $135,254	4,085 Added 18.64%	26,000 $829,000
Q2 2017 Aug 11, 2017	BUY	N/A	21,915	21,915 $635,000

616

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.4B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Bahl & Gaynor Inc, based on Form 13F filings with the SEC.

Stay updated on Bahl & Gaynor Inc with notifications on news.